4th Quarter - Report
VENABLE LLP for ENDO PHARMACEUTICALS INC
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Life Sciences Jobs and Investment Act (S. 1410; H.R. 2632).
| Lobbyist | Covered position, as disclosed |
|---|---|
| SAMUEL OLCHYK | — |
| ROBERT L SMITH | — |
Health Issues HCR
The Life Sciences Jobs and Investment Act of 2011. (S. 1410; H.R. 2632)
| Lobbyist | Covered position, as disclosed |
|---|---|
| SAMUEL OLCHYK | — |
| ROBERT L SMITH | — |
Pharmacy PHA
General issues affecting the pharmaceutical industry and bioequivelence. (Generic pharmaceutical user fee act; H.R. 5651.) The Life Sciences Jobs and Investment Act (S. 1410; H.R. 2632)
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM R NORDWIND | — |
| SAMUEL OLCHYK | — |
| ROBERT L SMITH | — |
| BART STUPAK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.